Form 4: Myomo Inc. Chief Medical Officer Harry Kovelman Reports Transaction
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports a transaction involving the disposal of 146 shares of common stock to cover income taxes from vesting restricted stock units.
Summary
- On April 3, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., disposed of 146 shares of common stock.
- The transaction was executed at a price of $2.97 per share.
- The disposal was to cover income taxes resulting from the vesting of restricted stock units on April 2, 2024.
- The transaction was completed pursuant to an irrevocable election made by Kovelman in conjunction with the original grant in November 2020.
- Following the transaction, Kovelman beneficially owns 133,581 shares of Myomo, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| November 2020 | Original grant of restricted stock units in conjunction with irrevocable election. |
| 04/02/2024 | Vesting of restricted stock units. |
| 04/03/2024 | Date of stock disposal to cover income taxes. |
| 04/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.